InMode Ltd. (INMD)
Pre-market:
| Previous close | 18.85 |
| Open | 18.67 |
| Bid | 18.62 x 400 |
| Ask | 18.69 x 400 |
| Day's range | 18.59 - 18.81 |
| 52-week range | 16.72 - 48.25 |
| Volume | |
| Avg. volume | 1,448,051 |
| Market cap | 1.577B |
| Beta (5Y monthly) | 2.20 |
| PE ratio (TTM) | 8.83 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
InMode to Present at Jefferies Healthcare Conference
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer, will present in-person at the Jefferies Healthcare Conference in New York on June 5, 2024.
- PR Newswire
InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is the first aesthetic company to officially partner with P1 Offshore Racing and sponsor the only female driver, Victoria Rand, as part of Class 1. This partnership signifies a historic step forward in motorsports, and reflects InMode's unwavering dedication to championing and empowering women.
- PR Newswire
InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M;
InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter ended March 31, 2024.
